1 |
Aln-65585 |
- |
- |
- |
- |
234 1件: 234 💬 |
2 |
Aln-go1 |
- |
- |
- |
- |
234 1件: 234 💬 |
3 |
Ca |
- |
- |
- |
- |
234 1件: 234 💬 |
4 |
Cald hr-d (high-risk, regimen c) |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
5 |
Cald hr-d (high-risk, regimen d) |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
6 |
Cald sr-a (standard-risk, regimen a) |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
7 |
Cald sr-b (standard-risk, regimen b) |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
8 |
Campath |
- |
- |
- |
- |
019 12件: 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 💬 |
9 |
Campath-1h |
- |
- |
- |
- |
019 6件: 19, 20, 60, 234, 285, 326 💬 |
10 |
Chenodeoxycholic acid |
Chenodeoxycholic acid |
1件: D00163 D00163 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
020 4件: 20, 96, 234, 263 💬 |
11 |
Cholic acid |
Cholic Acid |
1件: D10699 D10699 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
020 4件: 20, 234, 265, 310 💬 |
12 |
Cholic acids |
- |
- |
- |
- |
020 2件: 20, 234 💬 |
13 |
Clofarabine |
Clofarabine |
1件: D03546 D03546 💬 |
POLA1 3件: POLA1, POLA2, RRM1 💬 |
DNA replication 6件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
019 9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 💬 |
14 |
Cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
15 |
Cyclosporine a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 10件: 19, 20, 36, 49, 50, 53, 58, 60, 234, 283 💬 |
16 |
Dcr-1171x |
- |
- |
- |
- |
234 1件: 234 💬 |
17 |
Dcr-l1360 |
- |
- |
- |
- |
234 1件: 234 💬 |
18 |
Dcr-ph1 |
- |
- |
- |
- |
234 1件: 234 💬 |
19 |
Dcr-phxc |
- |
- |
- |
- |
234 1件: 234 💬 |
20 |
Hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 12件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
21 |
Hydroxychloroquine |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
013 23件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
22 |
Imd |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
23 |
Imd preparative regimen |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
24 |
Lumasiran |
Lumasiran |
1件: D11925 D11925 💬 |
HAO1 1件: HAO1 💬 |
Carbon metabolism 4件: Carbon metabolism, Glyoxylate and dicarboxylate metabolism, Metabolic pathways, Peroxisome |
234 1件: 234 💬 |
25 |
Melphalan |
Melphalan |
1件: D00369 D00369 💬 |
- |
- |
011 15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
26 |
Mycophenolate |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
27 |
Mycophenolate mofetil |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 32件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
28 |
Nedosiran |
- |
- |
- |
- |
234 1件: 234 💬 |
29 |
Osteopetrosis haploidentical only preparative regimen |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
30 |
Osteopetrosis only preparative regimen |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
31 |
Radiation: total body irradiation with marrow boosting |
- |
- |
- |
- |
019 2件: 19, 234 💬 |
32 |
Stem cell transplantation |
- |
- |
- |
- |
013 10件: 13, 19, 20, 46, 65, 90, 125, 164, 234, 326 💬 |
33 |
Sterile normal saline (0.9% nacl) |
- |
- |
- |
- |
062 3件: 62, 234, 254 💬 |
34 |
Ursodiol |
Ursodeoxycholic acid |
1件: D00734 D00734 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
008 6件: 8 , 20, 93, 97, 234, 299 💬 |